WEREWOLF THERAPEUTICS INC (HOWL) Stock Income Statement
NASDAQ:HOWL - Nasdaq - US95075A1079 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.14M | 1.89M | 19.94M | 16.40M | 0.00 | |||
| Operating Expenses | 75.57M | 75.48M | 60.45M | 72.46M | 50.09M | |||
| Research and Development | 56.65M | 56.43M | 41.78M | 53.76M | 35.27M | |||
| Selling, General, and Administrative Expenses | 18.92M | 19.05M | 18.67M | 18.70M | 14.82M | |||
| Operating Income | -74.42M | -73.59M | -40.50M | -56.06M | -50.09M | |||
| Interest Income/Expense | 781.00K | 2.02M | 4.28M | 1.91M | 100.00K | |||
| Other Income/Expense | 1.78M | 1.61M | -1.14M | 340.00K | 0.00 | |||
| Non Recurring Items | N/A | -553.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -72.41M | -70.52M | -37.37M | -53.81M | -49.98M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -72.41M | -70.52M | -37.37M | -53.81M | -201.93M | |||
| EBITDA | -72.65M | -71.78M | -38.74M | -54.96M | -49.87M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.64 | -1.63 | -1.05 | -1.86 | -7.39 | |||
| Non GAAP EPS | -1.64 | -1.63 | -1.04 | -1.88 | -88.35 | |||
| Statistics | ||||||||
| Profit Margin | -6335.17% | -3740.85% | -187.37% | -328.11% | N/A | |||
| Operating Profit Margin | -6511.20% | -3904.19% | -203.09% | -341.83% | N/A | |||
All data in USD